ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2306

Intratracheal Instillation of Omniscan in an Adenine-Induced Model of Chronic Renal Failure: A New Model of Nephrogenic Systemic Fibrosis

Peter J. Wermuth and Sergio A. Jimenez, Jefferson Institute of Molecular Medicine, Division of Connective Tissue Diseases and Scleroderma Center,Thomas Jefferson University, Philadelphia, PA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Animal models, Collagen, nephrogenic fibrosing dermopathy and renal disease

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud’s – Pathogenesis, Animal Models and Genetics

Session Type: Abstract Submissions (ACR)

Background/Purpose: Nephrogenic Systemic Fibrosis (NSF), a generalized progressive fibrotic disorder, occurs in some patients with renal insufficiency exposed to various gadolinium based contrast agents (GdBCA).  Currently, there is no animal model for human NSF.  Some studies using subtotal nephrectomized rats described cutaneous lesions characterized by slight dermal fibrosis and increased infiltration of CD34+ cells following systemic GdBCA administration. These lesions, however, failed to reproduce the severe dermal and tissue fibrosis and other histomorphological changes characteristic of human NSF.  One possible reason for this is that although subtotal nephrectomy replicates the decreased filtering capacity of human chronic renal failure, it fails to induce numerous other features that may be necessary for NSF development.  In this study, we treated mice with adenine-induced renal failure by intratracheal instillation of the GdBCA Omniscan to develop a more relevant model of NSF.

Methods: Chronic renal failure was induced in C57BL6/J mice by ad libitum feeding of standard rodent diet supplemented with 3% adenine for 30 days.  A single dose of either the GdBCA Omniscan (25 µL of a 0.5 M solution) or an equal volume of normal saline was administered to mice with normal renal function (controls) or with chronic renal failure by intratracheal instillation.  Mice were sacrificed 28 days post-instillation and tissues were isolated for analysis by histological examination (hematoxyllin/eosin and Masson’s trichrome stains. Assays of collagen content to assess the severity of tissue fibrosis were performed employing a standard hydroxyproline assay of hydrolyzed tissue samples.

Results: Histopathology studies showed mononuclear cell infiltration and fibrosis in lungs isolated from adenine-fed mice instilled with Omniscan but not in lungs from mice with normal renal function instilled with Omniscan nor in mice with either normal or ablated renal function instilled with saline. The pattern of fibrosis was predominantly peribronchial although substantial diffuse interstitial fibrosis was also observed.  Hydroxyproline content was increased ~3 fold in the lungs of renal failure mice treated with Omniscan compared to mice in all other treatment groups.

Conclusion: The present study demonstrates for the first time the ability to induce significant tissue fibrosis and increased collagen deposition in mice with adenine induced renal failure exposed to the gadolinium contrast agent Omniscan.  This inducible model of tissue fibrosis will be a valuable tool in studying the pathogenesis of NSF and other chemically-induced fibrotic disorders.


Disclosure:

P. J. Wermuth,
None;

S. A. Jimenez,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/intratracheal-instillation-of-omniscan-in-an-adenine-induced-model-of-chronic-renal-failure-a-new-model-of-nephrogenic-systemic-fibrosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology